Filter
1996
Text search:
France
Featured
201
389
Language
Document type
886
491
286
130
63
52
48
19
7
6
4
1
1
Countries
112
101
37
36
32
30
28
27
27
27
26
26
25
24
23
22
22
18
18
17
16
16
14
13
13
13
12
12
12
12
12
12
11
11
11
10
9
9
9
8
8
7
6
6
6
6
6
6
6
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
436
206
122
118
115
38
27
Toolboxes
212
209
146
116
75
70
68
66
62
56
56
52
47
46
45
41
39
31
25
22
21
15
11
9
8
2
Building laboratory testing capacity
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I
...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p
...
TECHNICAL NOTE III
WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2017
The WHO Regional Office for Europe, the WHO Collaborating Centre on Culture and Health at the University of Exeter (United Kingdom) and the National Institute of Mental Health (Czechia) convened a workshop on culture and reform of mental health care in central and eastern Europe on 2–3 October 201
...
The report focuses on several key areas where health outcomes are falling short, and provides insight into ways in which countries can improve the situation for their children and adolescents. Areas in focus include mental health, overweight/obesity and adolescent risk-taking behaviour.
The report
...
A stated objective of WHO’s European Mental Health Action Plan 2013–2020 is to ensure better information and knowledge for service planning, development, monitoring and evaluation, including requesting Member States to report on the indicators in the Plan.
Progress towards achieving the int
...
The European Mental Health Action Plan 2013–2020
recommended
Mental disorders are one of the top public health challenges in the WHO European Region, affecting about 25% of the population every year. In all countries, mental health problems are much more prevalent among the people who are most deprived. The WHO European Region therefore faces diverse challeng
...
Depression is a leading cause of non-fatal disease burden worldwide, with a lifetime prevalence of 9% among European adult men and 17% among European adult women.
The task at hand requires substantial investments in preventive mental health care, but the potential benefits can be equally rewarding.
...
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?
Harm reduction: evidence, impacts and challenges
-10-
Strategic Overview
Это коллективная монография, отчёт по вопросам и проблемам трудоустройства людей в разных странах. Цитируется Конвенция о правах инвалидов и то, каким образом соб
...
Health, Rights and Drugs
recommended
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Developmental disorders
Chapter C.2
2014 Edition
Mood disorders
Chapter E.4
2018 edition
Research Article
Journal of Addiction
Volume 2016, Article ID 2476164, 8 pages
http://dx.doi.org/10.1155/2016/2476164
Sudan Medical and Scientific Research Institute, Khartoum, Sudan
Received 26 November 2015; Accepted 27 January 2016
